A Comprehensive Bioinformatics Approach to Analysis of Variants: Variant Calling, Annotation, and Prioritization

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2025 Jan 2

PMID 39745615

Authors

Merve Nur Koroglu

Kaya Bilguvar

Affiliations

Soon will be listed here.

Abstract

Next-Generation Sequencing (NGS), also known as high-throughput sequencing technologies, has enabled rapid and efficient sequencing of large amounts of DNA and RNA. These technologies have revolutionized the field of genomics, transcriptomics, and proteomics and have been widely used in cancer research, leading to advances in clinical diagnosis and treatment. Improvements in the NGS technologies enabled millions of fragments to be sequenced simultaneously in a time- and cost-effective manner and resulted in large amount of genomic data which require efficient analysis methods. Analysis of the genomic data requires both efficient computer resources and bioinformatics approaches. This chapter details a comprehensive computational approach and analysis steps for genomic data analysis.

References

Logsdon G, Vollger M, Eichler E . Long-read human genome sequencing and its applications. Nat Rev Genet. 2020; 21(10):597-614. PMC: 7877196. DOI: 10.1038/s41576-020-0236-x. View

Majewski J, Schwartzentruber J, Lalonde E, Montpetit A, Jabado N . What can exome sequencing do for you?. J Med Genet. 2011; 48(9):580-9. DOI: 10.1136/jmedgenet-2011-100223. View

Rabbani B, Mahdieh N, Hosomichi K, Nakaoka H, Inoue I . Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders. J Hum Genet. 2012; 57(10):621-32. DOI: 10.1038/jhg.2012.91. View

Larson N, Oberg A, Adjei A, Wang L . A Clinician's Guide to Bioinformatics for Next-Generation Sequencing. J Thorac Oncol. 2022; 18(2):143-157. PMC: 9870988. DOI: 10.1016/j.jtho.2022.11.006. View

Christodoulou E, Yellapantula V, OHalloran K, Xu L, Berry J, Cotter J . Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors. NPJ Precis Oncol. 2023; 7(1):21. PMC: 9941464. DOI: 10.1038/s41698-023-00357-0. View

Pudjihartono M, Perry J, Print C, OSullivan J, Schierding W . Interpretation of the role of germline and somatic non-coding mutations in cancer: expression and chromatin conformation informed analysis. Clin Epigenetics. 2022; 14(1):120. PMC: 9520844. DOI: 10.1186/s13148-022-01342-3. View

Koboldt D . Best practices for variant calling in clinical sequencing. Genome Med. 2020; 12(1):91. PMC: 7586657. DOI: 10.1186/s13073-020-00791-w. View

Liao X, Zhu W, Zhou J, Li H, Xu X, Zhang B . Repetitive DNA sequence detection and its role in the human genome. Commun Biol. 2023; 6(1):954. PMC: 10509279. DOI: 10.1038/s42003-023-05322-y. View

Wygoda E, Loewenthal G, Moshe A, Alburquerque M, Mayrose I, Pupko T . Statistical framework to determine indel-length distribution. Bioinformatics. 2024; 40(2). PMC: 10868340. DOI: 10.1093/bioinformatics/btae043. View

10.

Olson N, Wagner J, Dwarshuis N, Miga K, Sedlazeck F, Salit M . Variant calling and benchmarking in an era of complete human genome sequences. Nat Rev Genet. 2023; 24(7):464-483. DOI: 10.1038/s41576-023-00590-0. View

11.

Srinivasan S, Kalinava N, Aldana R, Li Z, van Hagen S, Rodenburg S . Misannotated Multi-Nucleotide Variants in Public Cancer Genomics Datasets Lead to Inaccurate Mutation Calls with Significant Implications. Cancer Res. 2020; 81(2):282-288. DOI: 10.1158/0008-5472.CAN-20-2151. View

12.

Wang Q, Pierce-Hoffman E, Cummings B, Alfoldi J, Francioli L, Gauthier L . Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes. Nat Commun. 2020; 11(1):2539. PMC: 7253413. DOI: 10.1038/s41467-019-12438-5. View

13.

Karczewski K, Francioli L, Tiao G, Cummings B, Alfoldi J, Wang Q . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809):434-443. PMC: 7334197. DOI: 10.1038/s41586-020-2308-7. View

14.

Auton A, Brooks L, Durbin R, Garrison E, Kang H, Korbel J . A global reference for human genetic variation. Nature. 2015; 526(7571):68-74. PMC: 4750478. DOI: 10.1038/nature15393. View

15.

Glusman G, Caballero J, Mauldin D, Hood L, Roach J . Kaviar: an accessible system for testing SNV novelty. Bioinformatics. 2011; 27(22):3216-7. PMC: 3208392. DOI: 10.1093/bioinformatics/btr540. View

16.

Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. PMC: 2938201. DOI: 10.1093/nar/gkq603. View

17.

Cingolani P, Platts A, Wang L, Coon M, Nguyen T, Wang L . A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012; 6(2):80-92. PMC: 3679285. DOI: 10.4161/fly.19695. View

18.

McLaren W, Gil L, Hunt S, Riat H, Ritchie G, Thormann A . The Ensembl Variant Effect Predictor. Genome Biol. 2016; 17(1):122. PMC: 4893825. DOI: 10.1186/s13059-016-0974-4. View

19.

Rabbani B, Tekin M, Mahdieh N . The promise of whole-exome sequencing in medical genetics. J Hum Genet. 2013; 59(1):5-15. DOI: 10.1038/jhg.2013.114. View

20.

MacArthur D, Manolio T, Dimmock D, Rehm H, Shendure J, Abecasis G . Guidelines for investigating causality of sequence variants in human disease. Nature. 2014; 508(7497):469-76. PMC: 4180223. DOI: 10.1038/nature13127. View